|
HS Code |
914280 |
| Chemical Name | N-Acetylneuraminic Acid |
| Common Name | Sialic Acid |
| Molecular Formula | C11H19NO9 |
| Molar Mass | 309.27 g/mol |
| Appearance | White to off-white powder |
| Solubility In Water | Highly soluble |
| Melting Point | 192-193°C (decomposes) |
| Cas Number | 131-48-6 |
| Ph | Acidic in aqueous solution |
| Stability | Stable under normal temperatures and pressures |
As an accredited N-Acetylneuraminic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | N-Acetylneuraminic Acid is packaged in a 25g sealed amber glass bottle, labeled with product details and safety information. |
| Shipping | N-Acetylneuraminic Acid should be shipped in tightly sealed containers under cool, dry conditions, protected from light and moisture. Depending on the quantity and form, shipment may require cold packs or dry ice. All packages must comply with relevant chemical transport regulations and include clear labeling for safe handling and storage. |
| Storage | N-Acetylneuraminic Acid should be stored in a cool, dry place, away from direct sunlight and moisture. Keep it tightly sealed in its original container under inert atmosphere to prevent degradation. Ideally, store at 2–8°C (refrigerator temperature). Avoid exposure to extreme temperatures and strong oxidizing agents. If long-term storage is required, keep it at -20°C to maintain stability. |
|
N-Acetylneuraminic Acid is a critical raw material utilized across several highly regulated and technology-driven industrial sectors. As a direct manufacturer, we enable partners in pharmaceuticals, dietary supplements, advanced infant formula, and biotechnological research to achieve distinctive formulation and processing goals by supplying high-purity material. Each downstream application sector outlined below demonstrates the material’s functional contribution within specific regulated industrial processes. The pharmaceutical sector uses N-Acetylneuraminic Acid as an essential intermediate in the synthesis of glycan-based APIs and injectable drug substances, including those targeting rare metabolic and neuromuscular disorders. Manufacturers incorporate our material during glycosylation steps to achieve precise molecular profiles necessary for biological drug candidates and approved pharmaceutical agents. Control over source purity and contaminant levels is critical due to injectable safety requirements and the scrutiny of regulatory inspections. The acid is precisely dosed into reaction vessels during regulated API synthesis and purification steps, often following GMP-compliant dissolution, pH adjustment, and filtration. End products undergo strict batch release and documentation before packaging as bulk APIs or formulated solutions for sterile injectables distributed to hospital and clinical pharmacies. Industry compliance standards Typical usage ratio Downstream process integration Final product types In the nutraceutical sector, N-Acetylneuraminic Acid functions as a specialized ingredient in high-end dietary supplements targeting cognitive health, immunity, and aging. Manufacturers introduce the material directly into blending and granulation equipment after micronization and pre-mixing to achieve homogeneous dispersion in tablets, capsules, and powder blends. Strict compliance with food additive and supplement ingredient standards governs batch testing, allergen control, and solvent residue limits. Dosing is controlled to meet regional maximum allowable intake levels as declared on supplement facts panels. Finished products undergo stability testing and third-party verification before packaging for export or domestic retail distribution. Industry compliance standards Typical usage ratio Downstream process integration Final product types Global producers of infant formula integrate N-Acetylneuraminic Acid during downstream wet-mix blending to replicate the bioactive oligosaccharide content of human breast milk. Food-grade grade material undergoes strict trace metal, microbiological, and protein allergen panel testing before introduction to blending. The ingredient is uniformly blended with other glycans and milk base ingredients prior to UHT pasteurization and multi-stage spray drying, aligning closely with increasingly stringent regulatory targets for nutritional completeness in breast milk substitutes. Process control ensures the ingredient remains stable during heat and moisture cycles inherent to modern formula production plants. Final powder undergoes analytic confirmation of addition level and absence of prohibited contaminants. Industry compliance standards Typical usage ratio Downstream process integration Final product types Biotechnology firms utilize N-Acetylneuraminic Acid within chemically-defined and serum-free cell culture media. It serves as a key supplement for optimizing glycosylation and sialylation profiles during upstream mammalian cell fermentation, particularly in production of recombinant therapeutics, monoclonal antibodies, and viral vaccines. QC managers monitor trace impurities and endotoxin levels rigorously with each incoming lot. Operators dispense the material under aseptic conditions into sterilized mixing tanks as a dedicated process ingredient. The supplementation step occurs prior to seed train inoculation or during fed-batch culture supplementation, directly supporting cell growth and functional glycoprotein production. Post-fermentation, downstream purification proceeds through tangential flow filtration and chromatography steps ensuring removal of any excess unreacted sialic acid in the final purified biologic. Industry compliance standards Typical usage ratio
Downstream process integration
Final product types
|
Competitive N-Acetylneuraminic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
N-Acetylneuraminic Acid, often recognized as the chief sialic acid in humans, holds a special position in biochemical and pharmaceutical manufacturing. Our process starts with raw fermentation and purification steps that we have refined over years by listening closely to research needs. From the earliest pilot runs, our focus stuck on consistency in purity. It took more than a few setbacks to figure out how to maintain low endotoxin levels and control by-product formation under industrial conditions.
We produce N-Acetylneuraminic Acid in several grades. For biopharma clients, our typical batch offers purity upwards of 98%, with residual solvents below 0.5%. By running the process at strict pH and temperature windows, we keep color and odor to an absolute minimum. We noticed early that even a minor deviation results in yellow tinting or higher ash, leading to lost work on the client end. The solution required not just better equipment, but real-time process controls developed by our team.
Every drum leaving our plant follows a batch traceability protocol. Researchers and production chemists both want documentation. We share COA, MSDS, and data tied to the precise manufacturing date and stepwise analytics. This experience convinced us — providing only the minimum is not enough. Over the years, sharing full chromatograms, IR/NMR data, and documentation of enzyme origin has turned many one-time requests into decade-long partnerships.
N-Acetylneuraminic Acid finds its way into pharmaceutical intermediates, nutritional supplements, glycoprotein conjugates, and diagnostic kits. For pharma, process engineers count on low-biotin and ultra-low metal profiles when building glycosylation workflows. For infant formula manufacturers, batch-to-batch color uniformity makes quality checks quicker and less guesswork-intensive. Diagnostic companies want nucleic acid-level purity, so we use high-purity water for the final rinse — this single decision cut our reported contamination incidents near to zero.
Customers ask about solubility with every new project. Our crystalline grade dissolves rapidly in water and dilute alkali. The fine-powdered version meets needs for fast solution prep, crucial for high-throughput labs. Where long shelf storage comes in, granular models hold up better against caking and clumping, especially in humid zones. By working directly with formulators, we’ve designed models that minimize dust during weighing and pouring. The smallest quality tweak, like mesh size, leads to shorter cleaning times for downstream users.
Manufacturing N-Acetylneuraminic Acid puts a spotlight on quality control. Sialic acids act as key terminal sugars on glycoproteins and glycolipids, influencing stability and biological recognition in therapeutics. Even small batches with inconsistent sialylation result in wasted reagents downstream or failed biologic production. Experience teaches that taking extra time for in-line HPLC monitoring saves weeks later. Producing the acid in cGMP-compliant environments further ensures acceptance by global biopharma firms, something rarely possible with brokers or poorly monitored third parties.
Many researchers remember the years when N-Acetylneuraminic Acid required unreliable extraction from animal tissues. That method led to concern about animal-borne contaminants and batch non-uniformity. Our experience with enzyme-driven fermentation brought both predictability and safety. Enzyme lots undergo screening for DNA contamination, and every batch stays free from detectable animal-derived components. This shift encouraged a wave of trust from companies building biologicals for clinical use.
Solving crystal habit difficulties taught us much. Many users want a fine, free-flowing powder but not the dust hazard. We changed tumbler dryer times, switched to paddle dryers, and optimized post-drying sieving limits. These small but frustrating tweaks only became apparent through production-scale trials, not in glassware. Listening to feedback about hydrated clusters forming led us to install enclosed packaging lines. This minimized airborne moisture pickup, ensuring each bag ships dry and unreactive.
One quality assurance manager from a client company pointed out solubility drift during a project audit last year. Investigation traced the issue to small changes in fermentation air flow, which altered product microstructure. Tighter air regulation now keeps each lot within 3% of ideal bulk density, meeting tougher specs from diagnostic kit assembly lines. We no longer learn about issues after delivery — we catch problems before shipment leaves the dock. This routine creates two-way trust with technical teams we serve.
Lab managers worldwide complain about inconsistent batches from resellers. A label promising "99% pure" sometimes hides high borate, impurities, or near-invisible process debris. By manufacturing in-house, we hold raw data at hand, rather than third-party certificates. Over ten years, our analytical team refined both TLC and HPLC analysis, identifying minor contaminants that often stay invisible even to seasoned chemists.
Every time a new lot passes QC, we retain samples for future reference. This lets us resolve claims years later. Some clients once received material labeled as N-Acetylneuraminic Acid from outside brokers, only to find glycolic-acid peaks or unidentified sugars appearing in functional tests. By controlling every step from base fermentation to packaging, we guarantee that each order starts from a traceable source and matches full, compositional testing.
While brokers keep tight margins, we focus on customer longevity. Fielding requests for documentation led us to invest in more robust reporting, rather than cut corners. Sourcing direct from us means analytic reports come straight from the lab bench, not altered or summarized for sales. Many researchers have told us that trust from their regulatory teams counts just as much as the reagent cost itself.
Managing dust, exposure, and production safety sits at the core of daily operations. N-Acetylneuraminic Acid, though not especially hazardous by most global standards, presents real challenges if handled carelessly. During drum and bagging phase, our line workers rely on local exhaust hoods and autoclean dust filters. If a batch runs too dry, material loss spikes during packaging. Workers trained to spot dust buildup report in seconds, allowing maintenance to clean up before any risk accumulates.
We track all safety events, big and small, as learning points. Years ago, a small spill during transfer led to a refinery audit. This event brought new transfer protocols and firmware updates for the weigh-scale filling stations. Incidents now stay far below local thresholds, and site-wide drills ensure each shift can respond immediately. Providing open safety records to our customers in pharma and research wins trust, especially for those building critical supply chains.
Labs working with simple sugars might try to substitute N-Acetylneuraminic Acid with cheaper carbohydrates or lower-purity sialic acid extracts. The structure and reactivity set it apart. While glucose or galactose bring straightforward chemical conversion steps, the unique nine-carbon backbone of N-Acetylneuraminic Acid provides recognition elements in cell biology and immunology research. Substituting any other sugar almost never delivers the same bioactivity or glycan profiles in therapeutic design.
Within its own family, N-Acetylneuraminic Acid stands apart from variants like N-Glycolylneuraminic Acid. The latter might work for some animal models but brings unwanted immune response when used in human applications. Our food and supplement clients have asked about these differences many times. The answer boils down to immunology and purity demands. Consistent, synthetic, or fermentation-derived N-Acetylneuraminic Acid ensures finished product safety and repeatable clinical outcomes.
Comparing industrial grades, we have seen firsthand the pitfalls of sourcing from outside. Broader cut, lower-grade materials often carry calcium, magnesium, or transition metal impurities. Even small levels of these contaminants skew mass spectrometry readings and disrupt downstream chemistry. By keeping all major processing in a single line, we cut down contamination sources that plague market traders or third-party packagers.
Since the early days producing small lab batches, we've seen new applications emerge. Glycobiology teams ask for analytic-grade acid, nutrition researchers for food-compliant lots, and analytical kit manufacturers require ultra-low bioburden. By working directly with universities and global healthcare companies, we have tailored quality steps to each downstream need. Our close view into manufacturing and purification means we can adjust fermentation feeding schedules, pH, and even packaging times for any specification actually needed in the lab or factory.
In biopharmaceuticals, protein drugs depend on precise glycan finishing. By supplying batch-specific, enzymatically pure N-Acetylneuraminic Acid, our material enables high-yield synthesis. Nutritional supplement makers want long shelf-life and food-grade conforming materials. For them, we meet not only purity targets but low heavy metal and solvent levels aligned with regulatory standards.
What sets us apart is our willingness to change routines when new published data or permission standards warrant. The regulatory world never stands still. If a national health authority tightens impurity specs, we notify clients and incorporate those same levels into future runs. Every improvement revolves around close dialog — whether the request covers increased screening of organic acid residues or special packaging for high-humidity zones.
Quality doesn't end at the door. Many clients need reliable, temperature-protected supply lines with full trace documentation stepwise from us to their door. We learned hard lessons with early international shipments where customs delays cut shelf life or led to returns. Now every order leaves our facility with transport data loggers and detailed chain-of-custody sheets. This mindset of handling product like a critical reagent, rather than a simple commodity, reduces transit risk and keeps our customers supplied without interruption.
Customers valued our hands-on customs troubleshooting. A shipment held up by local authorities in Southeast Asia prompted us to review harmonized codes and improve labeling. Batch codes, storage temps, and hazard labels stay visible outside and inside every carton — not buried in shipping documents. We now update clients on tracking at each hub, which proved vital during shortages surrounding pandemic supply bottlenecks. These experiences shape every new shipment by close partnership, not just rulesets.
Every manufacturing choice impacts both workers and local communities. Our team scrutinizes waste acid, rinse water, and all off-gas streams. For years, routine waste treatment just followed local code — but a neighbor’s concern over faint odors shifted our perspective. Now, exhaust passes through extra scrubbers and carbon beds. Wastewater enters closed-loop treatment before discharge, allowing for continuous water-quality data collection. Over 90% of solid waste finds use as animal feed supplement or enters industrial compost, not landfill.
We share annual environmental reports with customers and invite auditors to review green chemistry practices. Our plant’s carbon footprint has dropped by over 15% since we integrated biobased solvents. Even such a modest percentage cut ripples through every batch, driving supplier partnerships focused on renewable inputs. These real improvements — tracked and published — win loyalty from clients balancing procurement quality, regulatory needs, and corporate social responsibility.
Simple claims about quality do not matter much without evidence. All labs and manufacturers working with our N-Acetylneuraminic Acid gain not just technical-grade chemical, but a reliable data trail showing each process step, from fermentation through to finished powder or crystal. This openness builds confidence during audits and registration, not just on-site but also with regulatory bodies on multiple continents.
Routine analysis goes beyond spec sheets. We use capillary electrophoresis, full NMR spectrometry, and microtrace heavy metal tests to support client documentation. If a technical or regulatory issue appears in an overseas batch, we run right back to retained samples and full production history. Years of joint root-cause troubleshooting with researchers taught us the importance of real transparency. Each problem faced and solution shared created deeper partnerships and less supplier churn.
In scenes from our own plant, we see the genuine value of people over protocols. A technical director recalling failed sialation reactions in his former lab asked for process walk-throughs and in-depth data before his first order. We shared years of method improvements, rather than marketing gloss. After successful validation, his group now relies on our material for every new therapy in the pipeline. This trust and direct documentation cannot come from those just trading chemicals — it’s built batch after batch by us.
Years of hands-on work with N-Acetylneuraminic Acid led us to respect the complex requirements chemists and production managers face. While other players favor broad marketing claims or focus on unit price, we focus on dependable batch quality, real documentation, and timely technical partnership. Experience from the shop floor, the packaging line, and customer audits shape every habit and routine here.
We continue refining what it means to produce N-Acetylneuraminic Acid, combining bioprocess innovation, feedback-driven improvements, and clear, batch-specific assistance any time users call on us for new or specialized needs. The result is a product supporting the next steps in biopharmaceuticals, diagnostics, and nutritional sciences — always made with reliability and transparency at the core.